Overview

Toradol (Ketorolac) in Breast Surgery to Reduce Pain & Opioid Use

Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether perioperative single-dose administration of ketorolac (Toradol) can reduce post-operative pain after breast surgery, thereby decreasing post-operative opioid use.
Phase:
Phase 1
Details
Lead Sponsor:
Carilion Clinic
Treatments:
Ketorolac
Ketorolac Tromethamine